Inhibiting microglia proliferation after spinal cord injury improves recovery in mice and nonhuman primates

Autor: Claire M. Bringuier, Jean-Christophe Perez, Emilie Aloy, Gaëtan Poulen, Nicolas Lonjon, Christophe Goze-Bac, Maida Cardoso, Yannick Nicolas Gerber, Hassan Boukhaddaoui, Florence E. Perrin, Emaëlle V.F. Artus, Nadine Mestre-Francés
Přispěvatelé: Mécanismes moléculaires dans les démences neurodégénératives (MMDN), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Laboratoire Charles Coulomb (L2C), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut des Neurosciences de Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Perrin, Florence, Université de Montpellier (UM)-Université Montpellier 2 - Sciences et Techniques (UM2)-Institut National de la Santé et de la Recherche Médicale (INSERM)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL), Institut des Neurosciences de Montpellier - Déficits sensoriels et moteurs (INM), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Regional Imaging Platform, Montpellier Ressources Imagerie (MRI), BioCampus, Montpellier, France, Institut Universitaire de France (IUF), Ministère de l'Education nationale, de l’Enseignement supérieur et de la Recherche (M.E.N.E.S.R.)
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology
[SDV]Life Sciences [q-bio]
primates
Medicine (miscellaneous)
microglia
Gene Expression
Transcriptome
Mice
0302 clinical medicine
Oral administration
Receptor
Pharmacology
Toxicology and Pharmaceutics (miscellaneous)

Spinal cord injury
ComputingMilieux_MISCELLANEOUS
0303 health sciences
Microglia
rodent
medicine.anatomical_structure
Receptors
Granulocyte-Macrophage Colony-Stimulating Factor

[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
medicine.symptom
Cheirogaleidae
Spinal cord pathology
Research Paper
proliferation
Neurogenesis
Central nervous system
Mice
Transgenic

Anisoles
Lesion
03 medical and health sciences
Downregulation and upregulation
medicine
Animals
[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Neuroinflammation
Spinal Cord Injuries
030304 developmental biology
Cell Proliferation
Inflammation
business.industry
Recovery of Function
Functional recovery
medicine.disease
spinal cord injury
Mice
Inbred C57BL

Disease Models
Animal

Pyrimidines
Neuroinflammatory Diseases
Cancer research
business
Neuroscience
030217 neurology & neurosurgery
Zdroj: Theranostics
Theranostics, 2021, 11 (18), pp.8640-8659. ⟨10.7150/thno.61833⟩
Theranostics, Ivyspring International Publisher, 2021, 11 (18), pp.8640-8659. ⟨10.7150/thno.61833⟩
ISSN: 1838-7640
DOI: 10.7150/thno.61833⟩
Popis: No curative treatment is available for any deficits induced by spinal cord injury (SCI). Following injury, microglia undergo highly diverse activation processes, including proliferation, and play a critical role on functional recovery.In a translational objective, we investigated whether a transient pharmacological reduction of microglia proliferation after injury is beneficial for functional recovery after SCI in mice and nonhuman primates. The colony stimulating factor-1 receptor (CSF1R) regulates proliferation, differentiation, and survival of microglia, we thus used an oral administration of GW2580, a CSF1R inhibitor.First, transient post-injury GW2580 administration in mice improves motor function recovery, promotes tissues preservation and/or reorganization (identified by coherent anti-stokes Raman scattering microscopy), and modulates glial reactivity.Second, post-injury GW2580-treatment in nonhuman primates reduces microglia proliferation, improves functional motor function recovery, and promotes tissue protection. Notably, three months after lesion microglia reactivity returned to baseline value.Finally, to initiate the investigation on molecular mechanisms induced by a transient post-SCI GW2580-treatment, we used microglia-specific transcriptomic analysis in mice. Notably, we detected a downregulation in the expression of inflammatory-associated genes and we identified genes that were up-regulated by SCI and further downregulated by the treatment.Thus, a transient oral GW2580 treatment post-injury may provide a promising therapeutic strategy for SCI patients and may also be extended to other central nervous system disorders displaying microglia activation.
Databáze: OpenAIRE